Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse™ Therapies
Go back to Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse™ Therapies| (NASDAQ: PGEN) | Delayed: 6.85 +0.17 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.68 | 52 Week High | $ | |||
| Open | $6.77 | 52 Week Low | $ | |||
| Day High | $6.92 | P/E | N/A | |||
| Day Low | $6.76 | EPS | $ | |||
| Volume | 2,061,152 | |||||
